Log in to save to my catalogue

Antioxidant Therapy in Cancer: Rationale and Progress

Antioxidant Therapy in Cancer: Rationale and Progress

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1103a2fca1a94c209d775db820594906

Antioxidant Therapy in Cancer: Rationale and Progress

About this item

Full title

Antioxidant Therapy in Cancer: Rationale and Progress

Publisher

Basel: MDPI AG

Journal title

Antioxidants, 2022-06, Vol.11 (6), p.1128

Language

English

Formats

Publication information

Publisher

Basel: MDPI AG

More information

Scope and Contents

Contents

Cancer is characterized by increased oxidative stress, an imbalance between reactive oxygen species (ROS) and antioxidants. Enhanced ROS accumulation, as a result of metabolic disturbances and signaling aberrations, can promote carcinogenesis and malignant progression by inducing gene mutations and activating pro-oncogenic signaling, providing a po...

Alternative Titles

Full title

Antioxidant Therapy in Cancer: Rationale and Progress

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_1103a2fca1a94c209d775db820594906

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1103a2fca1a94c209d775db820594906

Other Identifiers

ISSN

2076-3921

E-ISSN

2076-3921

DOI

10.3390/antiox11061128

How to access this item